INTI
INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI)
$05
About INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (INTI)
Inhibitor Therapeutics, Inc. engages in the discovery, development, and commercialization of therapeutics for patients with cancer. It focuses on SUBA-Itraconazole, a patented, oral formulation of Itraconazole, for treatment of prostate and lung cancers. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.14
52 Week Low
$0.04
Market cap
8.5M
Dividend yield
0.00%
Volume
--
Avg. volume
32,591
P/E ratio
-2.53
INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.14
52 Week Low
$0.04
Market cap
8.5M
Dividend yield
0.00%
Volume
--
Avg. volume
32,591
P/E ratio
-2.53